W

Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871

Watchlist Manager
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Watchlist
Price: 31.49 CNY 11.83% Market Closed
Market Cap: 6.4B CNY

Wall Street
Price Targets

Price Targets Summary
Wuhan Hvsen Biotechnology Co Ltd

There are no price targets for Wuhan Hvsen Biotechnology Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Wuhan Hvsen Biotechnology Co Ltd Competitors:
Price Targets
GFS
Globalfoundries Inc
-8% Downside
UUU
3U Holding AG
80% Upside

Revenue
Forecast

19% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
19% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

For the last 6 years the compound annual growth rate for Wuhan Hvsen Biotechnology Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 31%.

Operating Income
Forecast

-17% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
-17% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Wuhan Hvsen Biotechnology Co Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Wuhan Hvsen Biotechnology Co Ltd's stock price target?
Not Available

Wuhan Hvsen Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Wuhan Hvsen Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
31%

For the last 6 years the compound annual growth rate for Wuhan Hvsen Biotechnology Co Ltd's revenue is 19%. The projected CAGR for the next 3 years is 31%.

Back to Top